HBM Partners AG Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, HBM Partners AG has invested in 18 companies.

HBM Partners AG’s most common sectors for investment arelife science (87%) and medical products (5%) . The Firm’s most common investment types include venture (81%) and growth capital (11%). In total, HBM Partners AG has invested in 11 US states and 11 different countries.

In the last 3 years, HBM Partners AG has exited 17 companies. The Firm’s most common exit type is ipo (80%). HBM Partners AG’s largest (disclosed) exit occurred in 2022 when it sold Turning Point Therapeutics for $4.1B.

Join Mergr to view HBM Partners AG’s full profile and discover more mega-sized private equity firm investors just like it.

M&A Summary

  • M&A Total Activity101
    • M&A Buy Activity66
    • M&A Sell Activity35
  • Total Sectors Invested 7
  • Total Countries Invested 11
  • M&A Buy/Sell Connections 25

HBM Partners AG

Bundesplatz 1, PO-Box 1145,
Zug, 6301
Switzerland
+41 43 888 7171
www.hbmpartners.com

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase, Venture

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Nordic, Asia/Pacific, Central Asia/India

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 5 50
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (7.0/yr) # 31 17 15 3 - - 66
Sell (5.2/yr) # 9 9 10 3 1 3 35
vol $3.1B $4.1B $3.0B $10.2B
  101

Most Recent M&A

Company Date Value Type
Gynesonics, Inc. 2024-10-14 350M USD Trade Sale
Redwood City, California · www.gynesonics.com
Longboard Pharmaceuticals, Inc. 2024-10-14 2.6B USD Trade Sale
La Jolla, California · www.longboardpharma.com
Fangzhou, Inc. 2024-07-09 - IPO
Guangzhou, China · www.jianke.com
Mineralys Therapeutics, Inc. 2023-02-09 - IPO
Radnor, Pennsylvania · www.mineralystx.com
Cardialen, Inc. 2022-12-14 - Trade Sale
Minneapolis, Minnesota · www.cardialen.com
Acrivon Therapeutics, Inc. 2022-11-15 - IPO
Watertown, Massachusetts · www.acrivon.com
Mineralys Therapeutics, Inc. 2022-06-08 - Venture
Radnor, Pennsylvania · www.mineralystx.com
Turning Point Therapeutics, Inc. 2022-06-03 4.1B USD Trade Sale
San Diego, California · www.tptherapeutics.com
Aculys Pharma, Inc 2022-03-28 - Venture
Minato-ku, Japan · www.aculys.com
1000Farmacie S.P.A. 2022-02-07 - Venture
Napoli, Italy · www.1000farmacie.it
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 24 (80%) - 57 (86%) -
Medical Products 2 (7%) - 3 (5%) -
E-Commerce 2 (7%) - 2 (3%) -
Chemicals - - 1 (2%) -
Distribution 1 (3%) - 1 (2%) -
Internet Software and Services - - 1 (2%) -
Staffing 1 (3%) - 1 (2%) -
Total 30 - 66 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 17 (57%) - 44 (67%) -
  California 9 (30%) - 18 (27%) -
  Massachusetts 6 (20%) - 13 (20%) -
  Pennsylvania 1 (3%) - 4 (6%) -
  New York - - 2 (3%) -
  Delaware 1 (3%) - 1 (2%) -
  Texas - - 1 (2%) -
  Minnesota - - 1 (2%) -
  Illinois - - 1 (2%) -
  Florida - - 1 (2%) -
  Connecticut - - 1 (2%) -
  Colorado - - 1 (2%) -
China 4 (13%) - 7 (11%) -
Switzerland 1 (3%) - 4 (6%) -
Germany 2 (7%) - 2 (3%) -
India 2 (7%) - 2 (3%) -
Denmark 1 (3%) - 2 (3%) -
Italy 1 (3%) - 1 (2%) -
Colombia 1 (3%) - 1 (2%) -
Japan 1 (3%) - 1 (2%) -
France - - 1 (2%) -
Ireland - - 1 (2%) -
Total 30 - 66 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 23 (77%) - 53 (80%) -
Growth Capital 4 (13%) - 7 (11%) -
Stake Purchase 2 (7%) - 3 (5%) -
Add-on Acquisition - - 1 (2%) -
Buyout (LBO, MBO, MBI) - - 1 (2%) -
Joint Venture 1 (3%) - 1 (2%) -
Total 30 - 66 -

Exits by Deal Type

Type Total # Value
IPO 28 (80%) -
Trade Sale - Public Company 5 (14%) 10.2B (100%)
Shut Down 1 (3%) -
Trade Sale 1 (3%) -
Total 35 $10.2B

Deal Values

sell # Total
> $1B 3 $9.8B
$100M to $1B 1 $350M
< $100M 1 $78M
TOTAL $10.2B
Largest Turning Point Therapeutics, Inc.
$4.1B (2022-06-03)

M&A Connections

Deals
Exited to
Strategic(s)
14%
5 (14%)

Investor Summary

Investor Type

Private Equity Firm

Size

Mega

PE Assets

3.0B USD

Established

2001

Specialist/Generalist

Specialist

Leadership

Andreas Wicki

CEO

Dominique Kuttel

Head Business Development & Distribution

Thomas Heimann

Head Operations & Investment Solutions

Matthias Fehr

Head Private Equity

Ivo Staijen

Head Public Equity & Portfolio Manager

FAQ

When was HBM Partners AG founded?

HBM Partners AG was founded in 2001.

What type of investor is HBM Partners AG?

HBM Partners AG is a private equity firm.

Where is HBM Partners AG headquartered?

HBM Partners AG is headquartered in Zug, Switzerland.

How much capital does HBM Partners AG have under management?

HBM Partners AG has 3.0B USD under management.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal